glp 1 drugs and vision loss GLP-1 are associated with a 35% higher risk of NAION, an eye condition that can cause sudden loss. About 6 to 10 extra cases per 10,000 users over 3 years Emerging Concerns: GLP-1 Modulators and
Description
PMID:17306374

FDA Law Blog [blog on the Internet]
For people who have stalled on GLP-1 therapies or are trying to decide what actually drives sustainable fat lossnot just appetite suppressionunderstanding these differences matters more than the medication name

What are the research priorities for idiopathic intracranial hypertension
